Drugs of Abuse (DOA) Testing Market Expansion Continues, with Forecast Valuation of $11.21 Billion by 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Drugs of Abuse (DOA) Testing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market encompassing testing for drugs of abuse (doa) has recently experienced considerable expansion, projected to advance from a valuation of $7.3 billion in 2024 to $7.97 billion the following year, reflecting a compound annual growth rate (CAGR) of 9.2%; this past period's upward trend is chiefly linked to factors such as governmental mandates and employment guidelines, screening conducted prior to hiring, judicial and investigative processes, ongoing addiction recovery initiatives, and adherence to standards within the transit sector.

Drugs of Abuse (DOA) Testing Market Size Forecast: What's the Projected Valuation by 2029?
The market encompassing testing for substances of abuse is projected to experience substantial expansion over the forthcoming years, reaching a valuation of $11.21 billion by 2029, fueled by a compound annual growth rate (CAGR) of 8.9%. This upward trajectory through the predicted period stems from several factors, specifically broadening participation in testing within sports and athletics disciplines, heightened public knowledge and educational initiatives, an uptick in offenses linked to illicit substances, greater adoption of corporate health and wellness initiatives, alongside continuous evolution in the methodologies employed for such testing. Key shifts defining this market throughout the forecast horizon involve the growing preference for testing tools that are easily transported and hand-held, the integration of systematic laboratory data handling through information management systems (LIMS), a heightened focus on identifying synthetic compounds, surging consumer interest in cannabis* screening, and the incorporation of artificial intelligence (AI) capabilities to aid in making sense of testing outcomes.

View the full report here:
https://www.thebusinessresearchcompany.com/report/drugs-of-abuse-doa-testing-global-market-report

What Are the Drivers Transforming the Drugs of Abuse (DOA) Testing Market?
The escalating need for interventions concerning substance misuse is projected to fuel the expansion of the market dedicated to testing for drugs of abuse (DOA). Substance abuse, defined as consuming substances in amounts detrimental to the individual or those nearby, necessitates drug testing to pinpoint foreign compounds in the body; this procedure typically involves an initial screening followed by a confirmatory analysis to verify the presence of specific substances, thus linking the growing demand for addiction therapy directly to market advancement. To illustrate this trend, the UK government's official platform, GOV. UK, disclosed data in December 2023 showing that 290,635 adults received aid for drug and alcohol issues between April 2022 and March 2023, marking a minor uptick from the 289,215 cases reported the year prior, while treatment entries also climbed to 137,749, surpassing the 130,490 and 133,704 figures recorded in the immediately preceding two years, ultimately confirming that the rising call for substance abuse treatment serves as a key impetus for the DOA testing sector.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9381&type=smp

What Long-Term Trends Will Define the Future of the Drugs of Abuse (DOA) Testing Market?
Key players within the drugs of abuse (DOA) testing sector are concentrating their efforts on creating novel offerings, like Software-as-a-Service platforms, as a means to solidify their market standing. SaaS represents a delivery mechanism for software wherein an external vendor hosts applications, granting customer access to them via the internet. To illustrate this, in the month of December 2023, the science and technology firm Merck KGaA, headquartered in the US, introduced its Addison drug discovery software suite. This application accelerates the process of bringing new medicines and treatments to fruition and boosts their chances of success by integrating elements of computer-aided molecular design, machine learning algorithms, and generative artificial intelligence capabilities. Subsequently, the platform furnishes recommendations on optimal synthesis routes for these pharmaceuticals, effectively connecting the theoretical creation of virtual molecules with the practical realities of their production. By extracting latent knowledge embedded within vast informational sources, this software demonstrably enhances the probability that cutting-edge therapies will ultimately reach and benefit patient populations.

Which Segments in the Drugs of Abuse (DOA) Testing Market Offer the Most Profit Potential?
The drugs of abuse (doa) testingmarket covered in this report is segmented -

1) By Product And Service: Analyzers; Rapid Testing Devices; Consumables; Laboratory Services
2) By Sample Type: Urine; Hair; Oral Fluid; Breath
3) By Application: Pain Management; Criminal Justice; Workplace Screening
4) By End User: Hospitals; Diagnostic Laboratories; Forensic Laboratories; Other End Users

Subsegments:
1) By Analyzers: Immunoassay Analyzers; Chromatography-Based Analyzers; Mass Spectrometry Systems
2) By Rapid Testing Devices: Urine Test Kits; Saliva Test Kits; Hair Test Kits
3) By Consumables: Test Strips; Reagents; Sample Collection Devices
4) By Laboratory Services: Toxicology Testing; Confirmation Testing; Screening Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9381&type=smp

Which Firms Dominate the Drugs of Abuse (DOA) Testing Market by Market Share and Revenue in 2025?
Major companies operating in the drugs of abuse (DOA) testing market include Siemens AG, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., bioMérieux Inc., Dragerwerk AG & Co. KGaA, Aegis Sciences Corporation, NMS Labs, Clinical Reference Laboratory Inc., Cordant Health Solutions, Millennium Health, ACM Global Laboratories, Psychemedics Corporation, Alfa Scientific Designs Inc., Alere Toxicology Services, Omega Laboratories Inc., BioTek Laboratories, Premier Biotech Inc., Dominion Diagnostics LLC, Randox Toxicology Ltd., Cansford Laboratories Ltd., United States Drug Testing Laboratories Inc., American Bio Medica Corporation, Confirm BioSciences, Immunalysis Corporation, Medtox Diagnostics Inc., Forensic Fluids Laboratories

Which Regions Offer the Highest Growth Potential in the Drugs of Abuse (DOA) Testing Market?
North America was the largest region in the drugs of abuse (DOA) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global drugs of abuse (DOA) testing market report during the forecast period. The regions covered in the drugs of abuse (doa) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9381

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.